SANAVIA ONCOLOGY Trademark

Trademark Overview

On Wednesday, January 5, 2022, a trademark application was filed for SANAVIA ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the SANAVIA ONCOLOGY trademark a serial number of 97204172. The federal status of this trademark filing is REGISTERED as of Tuesday, October 24, 2023. This trademark is owned by Sanavia Oncology Inc.. The SANAVIA ONCOLOGY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of diagnostics and therapeutics for the detection and treatment of cancer
sanavia oncology

General Information

Serial Number97204172
Word MarkSANAVIA ONCOLOGY
Filing DateWednesday, January 5, 2022
Status700 - REGISTERED
Status DateTuesday, October 24, 2023
Registration Number7202946
Registration DateTuesday, October 24, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 29, 2022

Trademark Statements

Description of MarkThe mark consists of the terms "SANAVIA" and "ONCOLOGY", with the former term designed in a bold lowercase font that has a border emanating from the dotted "i" that extends and surrounds the term, and the term "ONCOLOGY" located below, in a smaller though sharper and lighter font that uses capital letters.
Pseudo MarkSANA VIA ONCOLOGY
Indication of Colors claimedColor is not claimed as a feature of the mark.
Translation of Words in MarkThe wording "SANAVIA" has no meaning in a foreign language.
Disclaimer with Predetermined Text"ONCOLOGY"
Goods and ServicesResearch and development of diagnostics and therapeutics for the detection and treatment of cancer

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 10, 2022
Primary Code042
First Use Anywhere DateTuesday, March 1, 2022
First Use In Commerce DateTuesday, March 1, 2022

Trademark Owner History

Party NameSanavia Oncology Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10014
Party NameSanavia Oncology Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10014
Party NameSanavia Oncology Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10014

Trademark Events

Event DateEvent Description
Tuesday, October 24, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 24, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, September 19, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, September 18, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, September 16, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, September 16, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 15, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 15, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 15, 2023NON-FINAL ACTION E-MAILED
Friday, September 15, 2023SU - NON-FINAL ACTION - WRITTEN
Tuesday, September 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 11, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 30, 2023USE AMENDMENT FILED
Monday, September 11, 2023SOU EXTENSION 1 GRANTED
Monday, July 24, 2023SOU EXTENSION 1 FILED
Friday, September 8, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 30, 2023NOTICE OF REVIVAL - E-MAILED
Wednesday, August 30, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, August 30, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, August 30, 2023NOTICE OF REVIVAL - E-MAILED
Wednesday, August 30, 2023PETITION TO REVIVE-GRANTED
Wednesday, August 30, 2023TEAS PETITION TO REVIVE RECEIVED
Monday, August 28, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 28, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 24, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 29, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 29, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 24, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 21, 2022EXAMINER'S AMENDMENT ENTERED
Friday, October 21, 2022ASSIGNED TO LIE
Friday, October 21, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, October 21, 2022EXAMINERS AMENDMENT E-MAILED
Friday, October 21, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, October 14, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 14, 2022NON-FINAL ACTION E-MAILED
Friday, October 14, 2022NON-FINAL ACTION WRITTEN
Tuesday, October 11, 2022ASSIGNED TO EXAMINER
Tuesday, January 11, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, January 10, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 8, 2022NEW APPLICATION ENTERED

Related Keywords

oncology sanavia treatment cancer detection therapeutics development diagnostics research